Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26597164 | 0.90 | THRB (0.37) | TSHRMEN1KMT2A | |
| SCHEMBL26597161 | 0.88 | MEN1 (0.32) | TSHRMEN1KMT2A | |
| SCHEMBL23718668 | 0.88 | TSHR (0.41) | TSHRNAAAMEN1KMT2AMAPT | |
| SCHEMBL26597170 | 0.84 | — | — | |
| SCHEMBL26597165 | 0.82 | L3MBTL1 (0.33) | TSHRMEN1KMT2AMAPTL3MBTL1 | |
| SCHEMBL26597171 | 0.82 | — | — | |
| SCHEMBL26597169 | 0.82 | ALDH1A1 (0.32) | TSHRMEN1KMT2AMAPT | |
| SCHEMBL2770601 | 0.79 | MEN1 (0.43) | TSHRMEN1KMT2AMAPTHTT | |
| SCHEMBL26597167 | 0.77 | ABCB11 (0.32) | TSHRL3MBTL1 | |
| SCHEMBL23736641 | 0.77 | THRB (0.42) | TSHRMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793732-B2 | Dental materials based on cyclopolymerizable crosslinkers | IVOCLAR VIVADENT AG (LI) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793732-B2 | Dental materials based on cyclopolymerizable crosslinkers | CBR3, CBR1, C1R | TSHR 2351/4885NAAA 4372/4885MEN1 4379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.